BackAvalyn Pharma Common Stock Overview
Avalyn Pharma Inc. Common Stock

Avalyn Pharma Common Stock Target Price

See Avalyn Pharma Common Stock's analyst price targets ($59) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$28.55

Average Target Price

$58.60105.3% upside

5 analysts in the last 4 months

High: $80 | Low: $51

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-13Morgan Stanley$5799.6% upsideOpen
2026-05-26Evercore ISIGavin Clark-Gartner$5178.6% upsideOpen
2026-05-26Morgan Stanley$5385.6% upsideOpen
2026-05-25Jefferies$5282.1% upsideOpen
2026-05-25Guggenheim$80180.2% upsideOpen

Avalyn Pharma Common Stock (AVLN) FAQ

As of the most recent data, AVLN shows a target price of $59. Scroll down for historical charts and peer comparison views.

If Avalyn Pharma Common Stock moved to the average analyst target of $59, shares would be roughly 105.3% higher than $28.55. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Avalyn Pharma Common Stock's earnings trajectory.

Besides this target price page, Stockcircle has Avalyn Pharma Common Stock's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $59) with ownership activity and broader fundamentals.

Avalyn Pharma Common Stock's target price is $59; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.